Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix Co-administration with Pneumovax 23 in Adults Aged 50 Years and Older
NCT02045836Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of herpes zoster vaccine (recombinant, adjuvanted) in herpes zoster (HZ), sponsored by GSK. Started Mar 2014; status: completed.
02
Drugs
herpes zoster vaccine (recombinant, adjuvanted)
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT02045836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045836.